|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/58 | (2006.01) |
| A61K 31/167 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 1210943 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02001670.5 |
| Date of filing the European patent application | 1998-09-09 | |
| (97) | Date of publication of the European application | 2002-06-05 |
| (45) | Date of publication and mention of the grant of the patent | 2006-06-14 |
| (46) | Date of publication of the claims translation | 2006-09-25 |
| (30) | Number | Date | Country code |
| 9703407 | 1997-09-19 | SE |
| (72) |
Bauer, Carl-Axel, SE
Trofast, Jan, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Budesonido ir formoterolio naujas panaudojimas |
| New use for budesonide and formoterol |
| Payment date | Validity (years) | Amount | |
| 2008-08-21 | 11 | 1000.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2008-12-15 |